Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) has signed a stock purchase agreement with Keystone Capital Partners. Keystone has a deep knowledge of ADIL business and is an ideal partner for the company. As per the agreement, Adial Pharmaceuticals will have the right to sell up